5.3.24
2024 AD/PD conference
7.11.23
Amyl Therapeutics receives additional €5M funding
4.9.22
Amyl Team at the International Society on amyloidosis
We had the pleasure of attending the First International AL Amyloidosis Meeting in Brussels on July 5-6, 2024. This two-day program offered a unique opportunity to explore all aspects of AL amyloidosis, with a particular focus on managing complications related to organ involvement. The event also provided valuable moments for patients and medical professionals to exchange insights and learn from each other’s experiences.